Cynthia G. Healy

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

Neeraj Agarwal, Arun Azad, Joan Carles et al. · The Lancet · 2023 · 499 citations

Medicine, Pharmacology, Pharmacotherapy +12

Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial

Johann S. de Bono, Niven Mehra, Giorgio V. Scagliotti et al. · The Lancet Oncology · 2021 · 277 citations · Full text

Medicine, Oncology, Pharmacology +16

First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

Karim Fizazi, Arun Azad, Nobuaki Matsubara et al. · Nature Medicine · 2023 · 127 citations · Full text

Medicine, Oncology, Pharmacology +17

Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer

Cynthia G. Healy, Jonathan W. Simons, Michael A. Carducci et al. · Cytometry · 1998 · 110 citations

Life Sciences, Immunology, Oncology +15

Expression of proliferation associated antigens in the cell cycle of synchronized mammalian cells

Wade E. Bolton, Warren R. Mikulka, Cynthia G. Healy et al. · Cytometry · 1992 · 63 citations

Life Sciences, Cell Biology, Molecular Biology +16